Get the Stockscreener App
0.9841
2.56%
-0.0259
Pre-market:
1.02
0.0359
+3.65%
Bio Green Med Solution Inc stock is traded at $0.9841, with a volume of 111.38K.
It is down -2.56% in the last 24 hours and up +0.64% over the past month.
Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
See More
Previous Close:
$1.01
Open:
$0.9751
24h Volume:
111.38K
Relative Volume:
1.39
Market Cap:
$4.82M
Revenue:
$81,000
Net Income/Loss:
$-6.93M
P/E Ratio:
-0.0116
EPS:
-84.7869
Net Cash Flow:
$-6.09M
1W Performance:
+8.20%
1M Performance:
+0.64%
6M Performance:
-79.24%
1Y Performance:
+0.00%
1-Day Range:
$0.91
$1.04
1-Week Range:
$0.832
$1.149
52-Week Range:
$0.7303
$6.70
Bio Green Med Solution Inc Stock (BGMS) Company Profile
Name
Bio Green Med Solution Inc
Sector
Industry
Phone
908-517-7330
Address
200 CONNELL DRIVE, BERKELEY HEIGHTS
Compare BGMS vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGMS
Bio Green Med Solution Inc
|
0.9841 | 4.82M | 81,000 | -6.93M | -6.09M | -84.79 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Bio Green Med Solution Inc Stock (BGMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Apr-27-20 | Resumed | ROTH Capital | Buy |
| Sep-07-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-16-15 | Initiated | H.C. Wainwright | Buy |
| Feb-04-10 | Initiated | Roth Capital | Buy |
| Oct-28-09 | Initiated | Merriman | Buy |
| Aug-12-08 | Initiated | Piper Jaffray | Buy |
| Mar-12-08 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-12-08 | Reiterated | Collins Stewart | Buy |
| Mar-12-08 | Reiterated | Needham & Co | Buy |
| Nov-27-07 | Reiterated | Cantor Fitzgerald | Buy |
| Aug-10-07 | Reiterated | Cantor Fitzgerald | Buy |
| Jun-04-07 | Reiterated | Needham & Co | Buy |
| Apr-23-07 | Initiated | Lazard Capital | Buy |
| Apr-10-07 | Initiated | Cantor Fitzgerald | Buy |
View All
Bio Green Med Solution Inc Stock (BGMS) Latest News
Net debt of Bio Green Med Solution Inc. – OTC:BGMSP - TradingView
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Stock List: Research Stocks from Around the World - GuruFocus
MTNB PE Ratio & Valuation, Is MTNB Overvalued - Intellectia AI
BGMS Technical Analysis & Stock Price Forecast - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BGMS SEC FilingsBio Green Med Solution Inc 10-K, 10-Q, 8-K Forms - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Bio Green Med Preferred Shares Set for Nasdaq Delisting - The Globe and Mail
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Amendment: Ong Yee Lung reports zero holdings in Bio Green Med (BGMS) - Stock Titan
Bio Green Med Solution (BGMS) amendment: filer reports 0 shares owned - Stock Titan
Bio Green Med Solution preferred stock to be delisted from Nasdaq Capital Market - Investing.com
Bio Green Med Solution Received Notice of Delisting - TradingView
[8-K] Bio Green Med Solution, Inc. Reports Material Event | BGMS SEC FilingForm 8-K - Stock Titan
CYCC SEC FilingsCyclacel Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
BGMSP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BGMS News | BIO GREEN MED SOLUTION INC (NASDAQ:BGMS) - ChartMill
Cyclacel Stock Tumbles Over 76% Since Regaining Nasdaq Compliance: What’s Ailing the Nanocap Biopharma Firm? - MSN
SILO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BGMS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BGMSP | Bio Green Med Solution, Stock Data, Price & News - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
2/6/2026 Market UpdateWinners: ASST, ADIL, RLYBLosers: EAF, ERNA, ANEBS&P 500: 2% - Trefis
Market Movers | Winners: ASST, ADIL, RLYB | Losers: EAF, ERNA, ANEB - Trefis
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Bio Green Med Solution Declares Quarterly Preferred Stock Dividend - TipRanks
CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
MSN Money - MSN
Tangible book value per share of Bio Green Med Solution, Inc. – MUN:UXI1 - TradingView — Track All Markets
Uni-Fuels Holdings Limited (UFG) - MSN
Bio Green Med Solution, Inc.6% Convertible Preferred Stock (Nasdaq:BGMSP) Stock Quote - FinancialContent
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
What date does Bio Green Med Solution, Inc.'s (BGMS) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
StockWatch: Wall Street’s Leaders and Laggards of 2025 - Genetic Engineering and Biotechnology News
Can Bio Green Med Solution Stock Hold Up When Markets Turn? - Trefis
Selling Bio Green Med Solution Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st
ARBCU IPO NewsSPAC ARC Group Acquisition I lowers unit offering by 40%, changes name, and overhauls management ahead of $150 million IPO - renaissancecapital.com
Is Bio Green Med Solution Stock Built to Withstand More Downside? - Trefis
[10-K/A] Bio Green Med Solution, Inc. Amends Annual Report | BGMS SEC FilingForm 10-K/A - Stock Titan
Best Stocks Under $5 Right Now - Benzinga
Bio Green Med Solution’s Strategic Shift and Q3 Results - MSN
Best Stocks Under $10 • Charts Updated Daily - Benzinga
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update - The Manila Times
Bio Green Med Solution Reports Q3 Financial Results - TipRanks
Bio Green Med Solution, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2025 - MarketScreener
Bio Green Med Solution Inc Stock (BGMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):